Search research articles
Contact Us
Filters
Showing results (71-80 of 191) with videos related to
Page
of 20
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 19, 2013
Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-β peptide
Rachel F Lane, John W Steele, Dongming Cai, et al.
Psychiatry Research
|
April 21, 2018
Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach
Alba Franquesa, Alberto Sainz-Cort, Sam Gandy, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 5, 2023
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 19, 2010
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals
Soong Ho Kim, Paul E Fraser, David Westaway, et al.
Biochemical Pharmacology
|
March 15, 2005
Emerging prospects for the disease-modifying treatment of Alzheimer's disease
Lary C Walker, Chris C Ibegbu, Charles W Todd, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 12, 2012
Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes
Rachel F Lane, Peter St George-Hyslop, Barbara L Hempstead, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 2, 2016
Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels
Henry H Ruiz, Tiffany Chi, Andrew C Shin, et al.
Journal of Neurochemistry
|
February 19, 2009
Phosphorylation of the amino-terminal region of X11L regulates its interaction with APP
Megumi Sakuma, Emi Tanaka, Hidenori Taru, et al.
Journal of Neurochemistry
|
August 4, 2004
Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding
S Parvathy, Michelle Ehrlich, Steve Pedrini, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2009
nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing
Marialaura Amadio, Alessia Pascale, Jun Wang, et al.
Page
of 20
Search research articles
Search
Showing results (71-80 of 191) with videos related to
Sort By:
Page
of 20
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 19, 2013
Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-β peptide
Rachel F Lane, John W Steele, Dongming Cai, et al.
Psychiatry Research
|
April 21, 2018
Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach
Alba Franquesa, Alberto Sainz-Cort, Sam Gandy, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 5, 2023
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness
Matthias Forstmann, Hannes S Kettner, Christina Sagioglou, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 19, 2010
Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals
Soong Ho Kim, Paul E Fraser, David Westaway, et al.
Biochemical Pharmacology
|
March 15, 2005
Emerging prospects for the disease-modifying treatment of Alzheimer's disease
Lary C Walker, Chris C Ibegbu, Charles W Todd, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 12, 2012
Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes
Rachel F Lane, Peter St George-Hyslop, Barbara L Hempstead, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 2, 2016
Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels
Henry H Ruiz, Tiffany Chi, Andrew C Shin, et al.
Journal of Neurochemistry
|
February 19, 2009
Phosphorylation of the amino-terminal region of X11L regulates its interaction with APP
Megumi Sakuma, Emi Tanaka, Hidenori Taru, et al.
Journal of Neurochemistry
|
August 4, 2004
Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding
S Parvathy, Michelle Ehrlich, Steve Pedrini, et al.
Journal of Alzheimer'S Disease : JAD
|
February 18, 2009
nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing
Marialaura Amadio, Alessia Pascale, Jun Wang, et al.
Page
of 20